title: Prevention of venous thromboembolism after injury.
authors.forename: G C
authors.initials: GC
authors.lastname: Velmahos
authors.forename: J
authors.initials: J
authors.lastname: Kern
authors.forename: L
authors.initials: L
authors.lastname: Chan
authors.forename: D
authors.initials: D
authors.lastname: Oder
authors.forename: J A
authors.initials: JA
authors.lastname: Murray
authors.forename: P
authors.initials: P
authors.lastname: Shekelle
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D012307:Risk Factors; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D014481:United States; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D014947:Wounds and Injuries / Q000150:complications*
chemical_list: D000925:Anticoagulants; D006493:Heparin